TY  - JOUR
  - Clarke G, Cryan JF, Dinan TG, Quigley EM
  - 2012
  - February
  - Alimentary Pharmacology And Therapeutics
  - Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria.
  - Validated
  - Altmetric: 11 ()
  - 35
  - 4
  - 403
  - 413
  - Irritable bowel syndrome (IBS) is a poorly understood, yet highly prevalent functional gastrointestinal disorder (FGID). The withdrawal, due to adverse events, of a number of pharmacological agents that were approved for the treatment of IBS has left a therapeutic vacuum for patients suffering from the disorder.
  - 10.1111/j.1365-2036.2011.04965.x
DA  - 2012/02
ER  - 

@article{V121848796,
   = {Clarke G,  Cryan JF and  Dinan TG,  Quigley EM },
   = {2012},
   = {February},
   = {Alimentary Pharmacology And Therapeutics},
   = {Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria.},
   = {Validated},
   = {Altmetric: 11 ()},
   = {35},
   = {4},
  pages = {403--413},
   = {{Irritable bowel syndrome (IBS) is a poorly understood, yet highly prevalent functional gastrointestinal disorder (FGID). The withdrawal, due to adverse events, of a number of pharmacological agents that were approved for the treatment of IBS has left a therapeutic vacuum for patients suffering from the disorder.}},
   = {10.1111/j.1365-2036.2011.04965.x},
  source = {IRIS}
}